Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Lucas

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|February 4, 2016
DNA Origami: Folded DNA-Nanodevices That Can Direct and Interpret Cell BehaviorCathal J Kearney, Christopher R Lucas, Fergal J O'Brien, et al.
Molecular Nutrition & Food Research|August 7, 2018
Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer PreventionBesma Abbaoui, Christopher R Lucas, Ken M Riedl, et al.
ACS Nano|July 1, 2016
Probing Nucleosome Stability with a DNA Origami NanocaliperJenny V Le, Yi Luo, Michael A Darcy, et al.
ACS Applied Materials & Interfaces|December 12, 2022
Multiplexed Detection of Molecular Interactions with DNA Origami Engineered Cells in 3D Collagen MatricesMelika Shahhosseini, Peter E Beshay, Ehsan Akbari, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 14, 2017
Engineering Cell Surface Function with DNA OrigamiEhsan Akbari, Molly Y Mollica, Christopher R Lucas, et al.
Journal of Proteomics|January 31, 2017
The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancerBesma Abbaoui, Kelly H Telu, Christopher R Lucas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2012
Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytesChristopher R Lucas, Hector M Cordero-Nieves, Robert S Erbe, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 20, 2015
Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia ModelPatrick D Halley, Christopher R Lucas, Emily M McWilliams, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 28, 2022
DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nontoxic up to High Doses In VivoChristopher R Lucas, Patrick D Halley, Amjad A Chowdury, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Advanced Materials (Deerfield Beach, Fla.)|February 4, 2016
DNA Origami: Folded DNA-Nanodevices That Can Direct and Interpret Cell BehaviorCathal J Kearney, Christopher R Lucas, Fergal J O'Brien, et al.
Molecular Nutrition & Food Research|August 7, 2018
Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer PreventionBesma Abbaoui, Christopher R Lucas, Ken M Riedl, et al.
ACS Nano|July 1, 2016
Probing Nucleosome Stability with a DNA Origami NanocaliperJenny V Le, Yi Luo, Michael A Darcy, et al.
ACS Applied Materials & Interfaces|December 12, 2022
Multiplexed Detection of Molecular Interactions with DNA Origami Engineered Cells in 3D Collagen MatricesMelika Shahhosseini, Peter E Beshay, Ehsan Akbari, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 14, 2017
Engineering Cell Surface Function with DNA OrigamiEhsan Akbari, Molly Y Mollica, Christopher R Lucas, et al.
Journal of Proteomics|January 31, 2017
The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancerBesma Abbaoui, Kelly H Telu, Christopher R Lucas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2012
Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytesChristopher R Lucas, Hector M Cordero-Nieves, Robert S Erbe, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 20, 2015
Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia ModelPatrick D Halley, Christopher R Lucas, Emily M McWilliams, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 28, 2022
DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nontoxic up to High Doses In VivoChristopher R Lucas, Patrick D Halley, Amjad A Chowdury, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
Pageof 1